NEW
YORK, Jan. 22, 2025 /PRNewswire/ -- Baird
Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or
the "Company"), a leader in minimally invasive Microwave Ablation
(MWA) technology, is expanding its presence into San Francisco, marking an important step in
its U.S. growth strategy. This expansion follows the recent J.P.
Morgan Health Conference in San
Francisco, highlighting the company's early success in
executing its strategic vision for medical innovation.
As part of this development, Dr. Terrence K. Trapp, an experienced
otolaryngologist, has integrated the Company's MWA system into his
practice, suggesting growing interest and recognition of minimally
invasive approaches for managing thyroid nodules.
Since receiving FDA 510(k) clearance in November 2023, Baird Medical has treated hundreds
of patients in the United States
with its MWA technology, all of whom have experienced significant
recovery and positive treatment outcomes. This growing adoption is
exemplified by physicians like Dr. Emad
Kandil, Professor of Surgery and Ellis Hanna Chair at
Tulane University, who has performed
over 100 MWA procedures. His experience further underscores the
clinical potential of this technology and the medical community's
increasing recognition of Baird Medical's innovations.
By collaborating with medical specialists and offering
comprehensive training and clinical support, Baird Medical is
actively expanding physician education and awareness of MWA
technology in the U.S. With its entry into San Francisco, the Company aims to further
improve access to minimally invasive treatment options, benefiting
both physicians and patients.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave
ablation (MWA) technology, offering advanced treatment solutions
for conditions such as thyroid nodules, breast disease, uterine
fibroids, and liver cancer. A publicly traded company on NASDAQ,
Baird Medical is dedicated to enhancing patient care through
precision, efficiency, and safety in its innovative medical
devices. For more information, please visit
https://bairdmed.com/
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the United States Private Securities Litigation
Reform Act of 1995. Forward-looking statements are statements that
are not historical facts and generally relate to future events or
Baird Medical's future financial or operational performance. In
some cases, you can identify forward-looking statements by
terminology such as "may," "might," "will," "should," "expect,"
"intend," "plan," "anticipate," "believe," "estimate," "predict,"
"potential," "continue," or the negative of these terms or other
similar expressions.
These forward-looking statements are subject to risks,
uncertainties, and assumptions that could cause actual results or
outcomes to differ materially from those expressed or implied.
These statements are based on estimates and assumptions that, while
considered reasonable by Baird Medical and its management, are
inherently uncertain. Risks and uncertainties may emerge over time,
and it is not possible to anticipate all potential factors that
could affect Baird Medical's business and financial
performance.
Factors that could cause actual results to differ materially
include, but are not limited to: (1) the risk that Baird Medical
may not achieve its expansion goals in the United States, China, or other markets; (2) changes in
economic, regulatory, or market conditions that impact Baird
Medical's operations; (3) the ability to realize anticipated
benefits from ongoing business initiatives or strategic
transactions; (4) regulatory developments and compliance with
applicable laws; (5) risks related to the development,
commercialization, and market acceptance of Baird Medical's
products; and (6) other risks and uncertainties detailed in Baird
Medical's filings with the SEC.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date they
are made. Baird Medical undertakes no obligation to update or
revise forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law. All forward-looking statements in this press release are
qualified in their entirety by this cautionary statement.
Contact:
Eric Huang, PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: ir@bairdmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/baird-medical-expands-into-san-francisco-advancing-us-market-growth-302356850.html
SOURCE BDMD
